The TRAF-interacting protein (TRIP) Is a regulator of keratinocyte proliferation

Journal of Investigative Dermatology

Volumn 131, Issue 2, 2011, Pages 349-357

  Almeida, Stéphanie ^a   Ryser, Stephan ^a   Obarzanek Fojt, Magdalena ^a   Hohl, Daniel ^a   Huber, Marcel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHATIDYLINOSITOL 3 KINASE; TRAF INTERACTING PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 78651393743     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.329     Document Type: Article

References (56)

1. Bailet O, Fenouille N, Abbe P et al. (2009) Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res 69:2748-56
2. Besse A, Campos AD, Webster WK et al. (2007) TRAF-interacting protein (TRIP) is a RING-dependent ubiquitin ligase. Biochem Biophys Res Commun 359:660-4
3. Bignell GR, Warren W, Seal S et al. (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160-5
4. Brennan P, Babbage JW, Thomas G et al. (1999) p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. Mol Cell Biol 19:4729-38
5. Bridge AJ, Pebernard S, Ducraux A et al. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34:263-4
6. Bruemmer D, Yin F, Liu J et al. (2003) Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells. Biochem Biophys Res Commun 303:251-8
7. Brummelkamp TR, Nijman SM, Dirac AM et al. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797-801
8. Cam H, Balciunaite E, Blais A et al. (2004) A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 16:399-411
9. Chen HZ, Tsai SY, Leone G (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 9:785-97
10. Chung YH, Jhun BH, Ryu SC et al. (2007) STP-C, an oncoprotein of herpesvirus saimiri augments the activation of NF-kappaB through ubiquitination of TRAF6. J Biochem Mol Biol 40:341-8
11. Coopman PJ, Do MT, Barth M et al. (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406:742-7
12. Cullen BR (2006) Enhancing and confirming the specificity of RNAi experiments. Nat Methods 3:677-81
13. Dahmane N, Lee J, Robins P et al. (1997) Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389:876-81
14. Dajee M, Lazarov M, Zhang JY et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421:639-43
15. Dlugosz AA, Yuspa SH (1993) Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol 120:217-25
16. Dlugosz AA, Yuspa SH (1994) Protein kinase C regulates keratinocyte transglutaminase (TGK) gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiate by calcium. J Invest Dermatol 102:409-14
17. Evans PC (2005) Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs. Expert Rev Mol Med 7:1-19
18. Gailani MR, Stahle-Backdahl M, Leffell DJ et al. (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78-81
19. Gao N, Zhang Z, Jiang BH et al. (2003) Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 310:1124-32
20. Grimm D, Streetz KL, Jopling CL et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441:537-41
21. Hennings H, Michael D, Cheng C et al. (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-54
22. Hirsch E, Ciraolo E, Ghigo A et al. (2008) Taming the PI3K team to hold inflammation and cancer at bay. Pharmacol Ther 118:192-205
23. Javier AF, Bata-Csorgo Z, Ellis CN et al. (1997) Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells. J Clin Invest 99:2094-9
24. Jerome-Morais A, Rahn HR, Tibudan SS et al. (2009) Role for protein kinase C-alpha in keratinocyte growth arrest. J Invest Dermatol 129:2365-75
25. Kaufman CK, Fuchs E (2000) It's got you covered. NF-kappaB in the epidermis. J Cell Biol 149:999-1004
26. Kovalenko A, Chable-Bessia C, Cantarella G et al. (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubi-quitination. Nature 424:801-5
27. Krishnan S, Intlekofer KA, Aggison LK et al. (2009) Central role of TRAF-interacting protein in a new model of brain sexual differentiation. Proc Natl Acad Sci USA 106:16692-7
28. Lee DA, Grossman ME, Schneiderman P et al. (2005) Genetics of skin appendage neoplasms and related syndromes. J Med Genet 42:811-9
29. Lee SY, Choi Y (1997) TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med 185:1275-85
30. Lee YS, Yuspa SH, Dlugosz AA (1998) Differentiation of cultured human epidermal keratinocytes at high cell densities is mediated by endogenous activation of the protein kinase C signaling pathway. J Invest Dermatol 111:762-6
31. Li L, Sampat K, Hu N et al. (2006) Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes. J Biol Chem 281:3237-43
32. Lim JH, Jono H, Koga T et al. (2007) Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS ONE 2:e1032
33. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-8
34. Lu JX (1992) Magnesium chelation inactivates beta-galactosidase in -20 degrees C storage. Biotechniques 12:177-81
35. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261-74
36. Moroni M, Soldatenkov V, Zhang L et al. (2004) Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64:7346-54
37. Paramio JM, Lain S, Segrelles C et al. (1998) Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation. Oncogene 17:949-57
38. Paramio JM, Segrelles C, Casanova ML et al. (2000) Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation. J Biol Chem 275:41219-26
39. Park ES, Choi S, Kim JM et al. (2007) Early embryonic lethality caused by targeted disruption of the TRAF-interacting protein (TRIP) gene. Biochem Biophys Res Commun 363:971-7
40. Rayman JB, Takahashi Y, Indjeian VB et al. (2002) E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 16:933-47
41. Regamey A, Hohl D, Liu JW et al. (2003) The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. J Exp Med 198:1959-64
42. Regl G, Kasper M, Schnidar H et al. (2004) The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene 23:1263-74
43. Ruiz S, Santos M, Segrelles C et al. (2004) Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 131:2737-48
44. Sakaguchi M, Miyazaki M, Takaishi M et al. (2003) S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 163:825-35
45. Seitz CS, Deng H, Hinata K et al. (2000) Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res 60:4085-92
46. Sledz CA, Holko M, De Veer MJ et al. (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834-9
47. Sur I, Ulvmar M, Jungedal R et al. (2009) Inhibition of NF-kappaB signaling interferes with phorbol ester-induced growth arrest of keratinocytes in a TNFR1-independent manner. J Recept Signal Transduct Res 29:44-51
48. Takahashi Y, Rayman JB, Dynlacht BD (2000) Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14:804-16
49. Thomas G, Hall MN (1997) TOR signalling and control of cell growth. Curr Opin Cell Biol 9:782-7
50. Tibudan SS, Wang Y, Denning MF (2002) Activation of protein kinase C triggers irreversible cell cycle withdrawal in human keratinocytes. J Invest Dermatol 119:1282-9
51. Trompouki E, Hatzivassiliou E, Tsichritzis T et al. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424:793-6
52. Wong BR, Josien R, Lee SY et al. (1998) The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem 273:28355-9
53. Yamada T, Fujieda S, Yanagi S et al. (2001) IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines. J Immunol 167:283-8
54. Yuspa SH, Kilkenny AE, Steinert PM et al. (1989) Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109:1207-17
55. Zhou Q, Geahlen RL (2009) The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells. Oncogene 28:1348-56
56. Zohlnhofer D, Nuhrenberg TG, Neumann FJ et al. (2004) Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties. Mol Pharmacol 65:880-9